IN2014CH07744A - - Google Patents
Info
- Publication number
- IN2014CH07744A IN2014CH07744A IN7744CH2014A IN2014CH07744A IN 2014CH07744 A IN2014CH07744 A IN 2014CH07744A IN 7744CH2014 A IN7744CH2014 A IN 7744CH2014A IN 2014CH07744 A IN2014CH07744 A IN 2014CH07744A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000062A ITFI20120062A1 (it) | 2012-03-21 | 2012-03-21 | Componenti per il trattamento di malattie correlate a ischemia-riperfusione. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014CH07744A true IN2014CH07744A (pt) | 2016-07-01 |
Family
ID=46147570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7744CH2014 IN2014CH07744A (pt) | 2012-03-21 | 2014-10-21 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9932352B2 (pt) |
| EP (1) | EP2855487B1 (pt) |
| JP (2) | JP6382791B2 (pt) |
| KR (2) | KR20150014910A (pt) |
| CN (1) | CN104395321B (pt) |
| AU (2) | AU2013237021B2 (pt) |
| CA (1) | CA2907652C (pt) |
| CY (1) | CY1118282T1 (pt) |
| DK (1) | DK2855487T3 (pt) |
| EA (1) | EA033160B1 (pt) |
| ES (1) | ES2601384T3 (pt) |
| HR (1) | HRP20161436T1 (pt) |
| HU (1) | HUE031535T2 (pt) |
| IL (1) | IL234796B (pt) |
| IN (1) | IN2014CH07744A (pt) |
| IT (1) | ITFI20120062A1 (pt) |
| LT (1) | LT2855487T (pt) |
| ME (1) | ME02553B (pt) |
| PL (1) | PL2855487T3 (pt) |
| PT (1) | PT2855487T (pt) |
| RS (1) | RS55337B1 (pt) |
| SI (1) | SI2855487T1 (pt) |
| SM (1) | SMT201700055B (pt) |
| WO (1) | WO2013140348A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10531655B2 (en) | 2011-12-02 | 2020-01-14 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
| IT202000008125A1 (it) | 2020-04-16 | 2021-10-16 | Minerva Srl | Acidi carbossilici 3-aza-biciclo[3.2.1]ottani e loro derivati per l’uso nel trattamento di infiammazioni |
| IT202200016614A1 (it) | 2022-08-04 | 2024-02-04 | Mimetech S R L | Udonitrectag e sue formulazioni ad uso topico per l’uso nel trattamento di patologie dermatologiche |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR75910B (pt) | 1981-04-21 | 1984-08-02 | Delalande Sa | |
| DE60042585D1 (de) | 2000-02-29 | 2009-09-03 | Univ Firenze | 3-Aza-6,8-dioxabicycloÄ3.2.1Üoctane und Analoga sowie diese enthaltende kombinatorische Bibliotheken |
| ITFI20020107A1 (it) * | 2002-06-19 | 2003-12-19 | Antonio Guarna | Composizioni farmaceutiche atte all'uso nel trattamento di patologie correlate all'azione di neutrofine e composti attivi in esse contenuti |
| CN1668614A (zh) * | 2002-07-18 | 2005-09-14 | 辉瑞产品公司 | 用作ccr1趋化因子受体拮抗剂双环哌啶衍生物 |
| WO2006015183A2 (en) * | 2004-07-30 | 2006-02-09 | Axonyx, Inc. | Pharmaceutical compositions for treating disorders of the skin |
| ATE540957T1 (de) * | 2008-11-25 | 2012-01-15 | Univ Firenze | Bicyclische peptidomimetikum-inhibitoren von aspartylproteasen zur behandlung von infektionskrankheiten |
-
2012
- 2012-03-21 IT IT000062A patent/ITFI20120062A1/it unknown
-
2013
- 2013-03-20 AU AU2013237021A patent/AU2013237021B2/en active Active
- 2013-03-20 EA EA201401045A patent/EA033160B1/ru unknown
- 2013-03-20 PT PT137210852T patent/PT2855487T/pt unknown
- 2013-03-20 ME MEP-2016-251A patent/ME02553B/me unknown
- 2013-03-20 RS RS20160926A patent/RS55337B1/sr unknown
- 2013-03-20 CN CN201380026577.3A patent/CN104395321B/zh active Active
- 2013-03-20 EP EP13721085.2A patent/EP2855487B1/en active Active
- 2013-03-20 LT LTEP13721085.2T patent/LT2855487T/lt unknown
- 2013-03-20 KR KR1020147029365A patent/KR20150014910A/ko active Application Filing
- 2013-03-20 ES ES13721085.2T patent/ES2601384T3/es active Active
- 2013-03-20 HU HUE13721085A patent/HUE031535T2/en unknown
- 2013-03-20 CA CA2907652A patent/CA2907652C/en active Active
- 2013-03-20 KR KR1020207012664A patent/KR102181346B1/ko active IP Right Grant
- 2013-03-20 SI SI201330411A patent/SI2855487T1/sl unknown
- 2013-03-20 WO PCT/IB2013/052205 patent/WO2013140348A1/en active Application Filing
- 2013-03-20 PL PL13721085T patent/PL2855487T3/pl unknown
- 2013-03-20 US US14/387,015 patent/US9932352B2/en active Active
- 2013-03-20 JP JP2015501034A patent/JP6382791B2/ja active Active
- 2013-03-20 DK DK13721085.2T patent/DK2855487T3/en active
-
2014
- 2014-09-22 IL IL234796A patent/IL234796B/en active IP Right Grant
- 2014-10-21 IN IN7744CH2014 patent/IN2014CH07744A/en unknown
-
2016
- 2016-11-02 HR HRP20161436TT patent/HRP20161436T1/hr unknown
- 2016-11-03 CY CY20161101112T patent/CY1118282T1/el unknown
-
2017
- 2017-01-25 SM SM201700055T patent/SMT201700055B/it unknown
- 2017-11-21 AU AU2017265037A patent/AU2017265037B2/en active Active
- 2017-12-12 US US15/839,148 patent/US20180155363A1/en not_active Abandoned
-
2018
- 2018-06-27 JP JP2018122052A patent/JP2018168173A/ja active Pending